Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial

Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Long-term results from a randomized, multicenter, double-blinded, controlled study

(2014) David W Dodick et al.   CEPHALALGIA

Peripheral neurostimulation in primary headaches

(2014) Giorgio Lambru et al.   NEUROLOGICAL SCIENCES

Pearls and pitfalls: Neurostimulation in headache

(2013) Tim P Jürgens et al.   CEPHALALGIA

The International Classification of Headache Disorders, 3rd edition (beta version)

(2013)   CEPHALALGIA

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline

(2013) Stephen D. Silberstein et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial

(2013) J. Schoenen et al.   NEUROLOGY

Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain

(2013) Rodrigo Noseda et al.   PAIN

Neurostimulation therapies for primary headache disorders

(2012) Delphine Magis et al.   CURRENT OPINION IN NEUROLOGY

Advances and challenges in neurostimulation for headaches

(2012) Delphine Magis et al.   LANCET NEUROLOGY

Disability in chronic daily headache: state of the art and future directions

(2011) Domenico D’Amico et al.   NEUROLOGICAL SCIENCES

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study

(2010) Joel R Saper et al.   CEPHALALGIA

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

(2010) SK Aurora et al.   CEPHALALGIA

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

(2010) HC Diener et al.   CEPHALALGIA

Chronic Migraine: Epidemiology and Disease Burden

(2010) Aubrey N. Manack et al.   Current Pain and Headache Reports

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

(2010) David W. Dodick et al.   HEADACHE

Clinical features, pathophysiology, and treatment of medication-overuse headache

(2010) Stefan Evers et al.   LANCET NEUROLOGY

Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials

(2010) Domenico D’Amico   NEUROLOGICAL SCIENCES

Global prevalence of chronic migraine: A systematic review

(2009) JL Natoli et al.   CEPHALALGIA

What predicts the change from episodic to chronic migraine?

(2009) Marcelo E Bigal et al.   CURRENT OPINION IN NEUROLOGY

Neurostimulation approaches to primary headache disorders

(2009) Thorsten Bartsch et al.   CURRENT OPINION IN NEUROLOGY

Acute Treatment of Intractable Migraine With Sphenopalatine Ganglion Electrical Stimulation

(2009) Stewart J. Tepper et al.   HEADACHE

Dynamic optimization of chronic migraine treatment: Current and future options

(2009) N. T. Mathew   NEUROLOGY

Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population-Based Study

(2008) Marcelo E. Bigal et al.   HEADACHE

The effect of sodium valproate on chronic daily headache and its subgroups

(2008) Vedat Ali Yurekli et al.   JOURNAL OF HEADACHE AND PAIN

When should “chronic migraine” patients be considered “refractory” to pharmacological prophylaxis?

(2008) Domenico D’Amico et al.   NEUROLOGICAL SCIENCES